Torrent Pharmaceuticals revenue and financials

TORNTPHARM · NSE · INR

Compare Torrent Pharmaceuticals
₹4,689.50Change from previous close: +1.70%Absolute change: +₹78.50

Close · November 20, 2026

In the fiscal year ended March 2026, Torrent Pharmaceuticals reported revenue of ₹139.8B (+21.39% year over year). Net income was ₹21.63B, a net margin of 15.5%.

Annual revenue · 2026: ₹139.8B
  1. ₹58.16B2017
  2. ₹59.5B2018
  3. ₹76.73B2019
  4. ₹79.39B2020
  5. ₹80.05B2021
  6. ₹85.08B2022
  7. ₹96.2B2023
  8. ₹107.28B2024
  9. ₹115.16B2025
  10. ₹139.8B2026

Fiscal year ending in March. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+21.39%
FY to Mar 2026 vs FY to Mar 2025
Net income growth
+13.19%
FY to Mar 2026 vs FY to Mar 2025
Net margin
15.5%
FY to Mar 2025: 16.6%

How Torrent Pharmaceuticals is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of INR; per-share values in INR; shares in millions.

Income statement · Annual
ItemFY to Mar 2026FY to Mar 2025FY to Mar 2024FY to Mar 2023FY to Mar 2022FY to Mar 2021FY to Mar 2020FY to Mar 2019FY to Mar 2018FY to Mar 2017
Total revenue139,797115,161107,27896,20285,08080,04679,39376,72859,49858,157
Cost of revenue33,88227,75926,86227,35224,42021,46421,66922,19716,73517,504
Gross profit105,91687,40280,41668,85060,66058,58257,72454,53142,76440,653
Selling, general and administrative27,31322,70820,16617,05215,48314,59714,42114,03811,3539,934
Research and development450304247313——————
Operating income34,39829,26125,72421,40017,69318,22815,18913,6879,52410,839
EBIT34,39829,26125,72421,40017,69318,22815,18913,6879,52410,839
EBITDA44,96836,75833,24928,02623,82324,29121,18019,61313,43913,773
Interest expense3,8472,5143,5263,3222,5293,5084,4845,0113,0482,029
Pre-tax income28,72226,72823,52118,47212,25915,26311,8665,6179,31010,881
Income tax7,3407,6166,9576,0194,4872,7441,6191,2542,5291,545
Net income21,63419,11316,56412,4527,77212,51910,2474,3636,7819,336
Net income to common shareholders21,63419,11316,56412,4527,77212,51910,2474,3636,7819,336
Basic EPS63.9256.4748.9436.7922.9636.9930.2812.8920.0427.58
Diluted EPS63.9256.4748.9436.7922.9636.9930.2812.8920.0427.58
Average shares (basic)338338338338338338338338338338
Average shares (diluted)338338338338338338338338338338
Dividend per share38.0032.0028.0022.0016.5017.508.508.507.007.00

Companies in the group: same industry, similar size